glutathione therapy from prodrugs to genes Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer Adaptive epigenetic response of glutathione
Adaptive epigenetic response of glutathione (GSH) related genes against lead (Pb) induced toxicity, in individuals chronically exposed to the metal ScienceDirect Prodrug approaches for the development of a long acting drug delivery systems PMC Prodrug conjugated tumor seeking commensals for targeted cancer therapy Nature Communications Frontiers Strategies for the development of stimuli responsive small molecule prodrugs for cancer treatment
Pay in 4 interest-free payments of $6.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19



